Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: Efficacy of anti-tumor necrosis factor α therapy

Journal of Clinical Rheumatology

Volumn 18, Issue 8, 2012, Pages 413-415

  Bruzzese, Vincenzo ^a  

^a UOC Medicina Clinica e Reumatologia   (Italy)

Author keywords

acne conglobata; and axial spondyloarthritis; infliximab therapy; pyoderma gangrenosum; suppurative hidradenitis

Indexed keywords

C REACTIVE PROTEIN; ETANERCEPT; HLA B27 ANTIGEN; INFLIXIMAB; ISONIAZID; NONSTEROID ANTIINFLAMMATORY AGENT;

ACNE CONGLOBATA; ADULT; ARTICLE; AXIAL SPONDYLOARTHRITIS; BONE DISEASE; BONE EDEMA; CASE REPORT; CLINICAL ASSESSMENT; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; HISTOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCRIPTION; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REMISSION; SPONDYLARTHRITIS; SUPPURATIVE HIDRADENITIS; TREATMENT FAILURE; TREATMENT RESPONSE; TUBERCULIN TEST;

ACNE VULGARIS; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; HIDRADENITIS SUPPURATIVA; HUMANS; INFUSIONS, INTRAVENOUS; ISONIAZID; MALE; PYODERMA GANGRENOSUM; SPONDYLARTHRITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871767020     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318278b84c     Document Type: Article

References (18)

1. Ruocco E, Sangiuliano S, Gravina AG, et al. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009;23: 1008-1017.
2. Grant A, Gonzalez T, Montgomery MO, et al. Infliximab therapy for patients with moderate to severe hidradenitis suppurative: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62:205-217.
3. Hoff N-P, Gerber PA. Pyoderma gangrenosum associated with chronic polyarthritis. CMAJ. 2011;183:1746.
4. Rosner IA, Richter DE, Huettner TL, et al. Spondyloathropathy associated with hidradenitis suppurative and acne conglobata. Ann Intern Med. 1982;97:520-525. (Pubitemid 12000695)
5. Rosner IA, Burg CG, Wisnieski JJ, et al. The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata. J Rheumatol. 1993;20:684-687. (Pubitemid 23138859)
6. Libow LF, Friar DA. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis. 1999;64:87-90.
7. Leybishkis B, Fasseas P, Ryan KF, et al. Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy. Am J Med Sci. 2001;321:195-197. (Pubitemid 32209923)
8. Velez A, Alcala J, Fernandez-Roldan JC. Pyoderma gangrenosum associated with acne conglobata. Clin Exp Dermatol. 1995;20:496-498. (Pubitemid 26080258)
9. Ah-Weng A, Langtry JAA, Velangi S, et al. Pyoderma gangrenosum associated with hidradenitis suppurativa. Clin Exp Dermatol. 2005;30:669-671. (Pubitemid 41499825)
10. Braun-Falco M, Kovnerystyy O, Lohse P, et al. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)Va new autoinflammatory syndrome distinct from PAPA syndrome [published online ahead of print]. J Am Acad Dermatol. 2012;66:409-412.
11. Lindor NM, Arsenault TM, Solomon H, et al. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997;72:611-615. (Pubitemid 27330245)
12. Tallon B, Corkill M. Peculiarities of PAPA syndrome. Rheumatology. 2006;45:1140-1143. (Pubitemid 44542104)
13. Sieper J, van der Heijde D, Landewe R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts form the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68:784-788.
14. Brooklin TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomized, double blind, placebo controlled trial. Gut. 2006;55:505-509.
15. Edrees AF, Kaplan DL, Adou NI. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-> levels. J Clin Rheumatol. 2002;8:273-275.
16. Tofteland ND, Shaver TS. Clinical efficacy of etanercept for treatment of PAPA syndrome. J Clin Rheumatol. 2010;16:244-245.
17. Disla E, Quayum B, Cuppari GG, et al. Successful use of etanercept in a patients with pyoderma gangrenosum complicating rheumatoid arthritis. J Clin Rheumatol. 2004;10:50-52. (Pubitemid 38197536)
18. Alhusayen R, Shear NH. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say? Am J Clin Dermatol. 2012;13:283-291.